CrestPoint Capital Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-6,600
Closed -$259K 224
2016
Q3
$259K Sell
6,600
-37,500
-85% -$1.53M 0.13% 196
2016
Q2
$1.8M Buy
44,100
+200
+0.5% +$7.99K 0.96% 23
2016
Q1
$1.8M Buy
43,900
+15,400
+54% +$570K 0.98% 21
2015
Q4
$1.04M Sell
28,500
-2,500
-8% -$95.5K 0.59% 52
2015
Q3
$1.12M Buy
31,000
+20,500
+195% +$788K 0.64% 49
2015
Q2
$423K Hold
10,500
0.22% 147
2015
Q1
$453K Buy
10,500
+5,900
+128% +$256K 0.24% 147
2014
Q4
$207K Sell
4,600
-1,000
-18% -$40.7K 0.11% 218
2014
Q3
$214K Buy
5,600
+60
+1% +$2.43K 0.13% 203
2014
Q2
$225K Hold
5,540
0.13% 200
2014
Q1
$227K Buy
+5,540
New +$211K 0.14% 198

Other funds holding ORCL

CrestPoint Capital Management's ORCL Position: Q4 2016 in Review

CrestPoint Capital Management sold out of Oracle (ORCL) in Q4 2016, closing a stake of 6,600 shares — an estimated $259K sold.

CrestPoint Capital Management first reported a position in ORCL in Q1 2014 and held it in 11 quarters. The position peaked at $1.8M in Q2 2016. 1,528 funds tracked by Wall St. Rank hold ORCL as of Q4 2016.

  • CrestPoint Capital Management reported no remaining Oracle position as of Q4 2016 after selling out during the quarter.
  • CrestPoint Capital Management sold 6,600 Oracle shares in Q4 2016, an estimated $259K.
  • CrestPoint Capital Management first reported a position in Oracle in Q1 2014 and held it in 11 quarters.
  • CrestPoint Capital Management's Oracle position peaked at $1.8M in Q2 2016.
  • 1,528 funds tracked by Wall St. Rank held Oracle as of Q4 2016.

Based on CrestPoint Capital Management's 13F filing for Q4 2016, filed 19 Jan 2017.